Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.58
0.02 (1.28%)
At close: Aug 15, 2025, 3:59 PM
1.57
-0.63%
After-hours: Aug 15, 2025, 04:04 PM EDT

Repare Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-16.74M -30.04M -28.67M -34.41M -34.77M 13.16M -28.03M -18.88M -11.95M -34.94M -31.66M 75.46M -38.09M -34.76M -28.29M -30.89M -26.31M -21.42M
Depreciation & Amortization
1.04M 1.19M 454K 478K 488K 501K 506K 498K 506K 441K 455K 484K 523K 516K 368K 369K 412K 322K
Stock-Based Compensation
2.07M 3.98M 4.93M 5.25M 6.52M 6.47M 6.36M 6.38M 6.26M 6.06M 5.14M 5.05M 4.75M 4.75M 3.9M 3.69M 3.18M 2.06M
Other Working Capital
-2.31M -3.09M 1.79M -4.95M -1.8M -13.04M -2.47M -19.7M -30.03M -1.6M -6.11M 22.08M 1.99M 1.04M 731K -4.24M 4.72M 3.42M
Other Non-Cash Items
-2.26M 24K -267K -719K -1.1M -704K 9.71M 551K 545K -1.23M -4.63M 552K 464K 525K 2.89M 554K 430K 359K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -10.8M -1.87M -2.1M n/a 7.48M -1.25M -1.29M -1.31M -777K -805K -452K -174K
Change in Working Capital
-445K -4.28M -3.77M -1.14M -1.65M -7.5M -5.9M -19.55M -27.62M -2.12M -6.42M 8.72M 5.46M 270K 1.18M -5.69M 4.68M 4.63M
Operating Cash Flow
-16.34M -29.13M -27.32M -30.54M -30.51M 11.93M -28.16M -32.87M -34.35M -31.79M -29.64M 88.16M -28.19M -30.01M -20.74M -32.77M -18.06M -14.23M
Capital Expenditures
n/a n/a n/a n/a n/a n/a -398K n/a -1.06M -475K 1.72M -266K -1.57M -487K -165K -324K -429K -772K
Cash Acquisitions
1M n/a n/a n/a n/a n/a -32.28M n/a -29.41M 6.21M -32.34M n/a -260K n/a 40K n/a n/a n/a
Purchase of Investments
-38.58M -7.87M -19.22M -11.92M -12.88M -89.33M -4.72M -28.5M -47.09M -98.71M -42.66M -209.91M -2.24M -1.76M -2.27M -1.76M -3.44M n/a
Sales Maturities Of Investments
37M 36.66M 50.81M 43M 20M 69.02M 37M 53M 76.5M 92.5M 75M 1.25M 2.5M 2.65M 2M 1.7M 3.75M n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 32.28M n/a 29.41M -6.21M 32.34M -208.66M 260K 890K 40K -65K 312K n/a
Investing Cash Flow
-586K 28.79M 31.59M 31.08M 7.12M -20.32M 31.88M 24.5M 28.35M -6.69M 34.06M -208.93M -1.31M 403K -398K -389K -117K -772K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a 79K 1K n/a 11.29B n/a n/a n/a n/a n/a 433K n/a n/a 213K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 40K 413K 165K 269K 205K 241K 274K 363K 449K 183K
Financial Cash Flow
n/a 79K 1K 166K n/a 375K 105K 284K 40K 413K 165K 269K 205K 241K 94.56M 363K 449K 183K
Net Cash Flow
-16.8M -262K 4.18M 721K -23.4M -8.05M 3.9M -8.18M -5.92M -38.06M 4.33M -120.64M -29.3M -29.29M 73.43M -32.86M -17.76M -14.78M
Free Cash Flow
-16.34M -29.13M -27.32M -30.54M -30.51M 11.93M -28.55M -32.87M -35.41M -32.26M -27.92M 87.89M -29.76M -30.49M -20.9M -33.1M -18.49M -15M